THE STUDY OF OSTEOPROTECTIVE PROPERTIES OF NANOPARTICULATED FORMS OF RESVERATROL AND LOSARTAN

The study demonstrated that endothelial dysfunction of bone microvasculature and deterioration of regional blood flow in bone developed eight weeks after ovariectomy in female white Wistar rats thus raising the risk of generalized osteoporosis. Nanoparticulated forms of losartan and resveratrol poss...

Full description

Bibliographic Details
Main Authors: Ivan Koklin, Oleg Gudyrev, Alexander Faitelson
Format: Article
Language:English
Published: Belgorod National Research University 2015-12-01
Series:Research Results in Pharmacology
Subjects:
Online Access:https://rrpharmacology.pensoft.net/article/31024/download/pdf/
_version_ 1797427543479943168
author Ivan Koklin
Oleg Gudyrev
Alexander Faitelson
author_facet Ivan Koklin
Oleg Gudyrev
Alexander Faitelson
author_sort Ivan Koklin
collection DOAJ
description The study demonstrated that endothelial dysfunction of bone microvasculature and deterioration of regional blood flow in bone developed eight weeks after ovariectomy in female white Wistar rats thus raising the risk of generalized osteoporosis. Nanoparticulated forms of losartan and resveratrol possessing endothelioprotective action effectively prevented reduction of regional microcirculation in bone tissue through keeping it at the same level as intact rats had. It allowed maintaining an adequate level of bone remodeling processes which was manifested in slowing of thinning of bone trabeculas and in prevention of possible microfractures in them.
first_indexed 2024-03-09T08:46:26Z
format Article
id doaj.art-00ce7f046fc049c29e57edbba7d6fe91
institution Directory Open Access Journal
issn 2658-381X
language English
last_indexed 2024-03-09T08:46:26Z
publishDate 2015-12-01
publisher Belgorod National Research University
record_format Article
series Research Results in Pharmacology
spelling doaj.art-00ce7f046fc049c29e57edbba7d6fe912023-12-02T15:12:33ZengBelgorod National Research UniversityResearch Results in Pharmacology2658-381X2015-12-0111283310.18413/2500-235X-2015-1-4-32-3831024THE STUDY OF OSTEOPROTECTIVE PROPERTIES OF NANOPARTICULATED FORMS OF RESVERATROL AND LOSARTANIvan KoklinOleg GudyrevAlexander FaitelsonThe study demonstrated that endothelial dysfunction of bone microvasculature and deterioration of regional blood flow in bone developed eight weeks after ovariectomy in female white Wistar rats thus raising the risk of generalized osteoporosis. Nanoparticulated forms of losartan and resveratrol possessing endothelioprotective action effectively prevented reduction of regional microcirculation in bone tissue through keeping it at the same level as intact rats had. It allowed maintaining an adequate level of bone remodeling processes which was manifested in slowing of thinning of bone trabeculas and in prevention of possible microfractures in them.https://rrpharmacology.pensoft.net/article/31024/download/pdf/osteoporosisendothelial dysfunctionbivaloslo
spellingShingle Ivan Koklin
Oleg Gudyrev
Alexander Faitelson
THE STUDY OF OSTEOPROTECTIVE PROPERTIES OF NANOPARTICULATED FORMS OF RESVERATROL AND LOSARTAN
Research Results in Pharmacology
osteoporosis
endothelial dysfunction
bivalos
lo
title THE STUDY OF OSTEOPROTECTIVE PROPERTIES OF NANOPARTICULATED FORMS OF RESVERATROL AND LOSARTAN
title_full THE STUDY OF OSTEOPROTECTIVE PROPERTIES OF NANOPARTICULATED FORMS OF RESVERATROL AND LOSARTAN
title_fullStr THE STUDY OF OSTEOPROTECTIVE PROPERTIES OF NANOPARTICULATED FORMS OF RESVERATROL AND LOSARTAN
title_full_unstemmed THE STUDY OF OSTEOPROTECTIVE PROPERTIES OF NANOPARTICULATED FORMS OF RESVERATROL AND LOSARTAN
title_short THE STUDY OF OSTEOPROTECTIVE PROPERTIES OF NANOPARTICULATED FORMS OF RESVERATROL AND LOSARTAN
title_sort study of osteoprotective properties of nanoparticulated forms of resveratrol and losartan
topic osteoporosis
endothelial dysfunction
bivalos
lo
url https://rrpharmacology.pensoft.net/article/31024/download/pdf/
work_keys_str_mv AT ivankoklin thestudyofosteoprotectivepropertiesofnanoparticulatedformsofresveratrolandlosartan
AT oleggudyrev thestudyofosteoprotectivepropertiesofnanoparticulatedformsofresveratrolandlosartan
AT alexanderfaitelson thestudyofosteoprotectivepropertiesofnanoparticulatedformsofresveratrolandlosartan
AT ivankoklin studyofosteoprotectivepropertiesofnanoparticulatedformsofresveratrolandlosartan
AT oleggudyrev studyofosteoprotectivepropertiesofnanoparticulatedformsofresveratrolandlosartan
AT alexanderfaitelson studyofosteoprotectivepropertiesofnanoparticulatedformsofresveratrolandlosartan